LFMGX
Price
$21.57
Change
-$1.07 (-4.73%)
Updated
Dec 18 closing price
VEXRX
Price
$113.98
Change
-$4.46 (-3.77%)
Updated
Dec 18 closing price
Ad is loading...

LFMGX vs VEXRX

Header iconLFMGX vs VEXRX Comparison
Open Charts LFMGX vs VEXRXBanner chart's image
Lord Abbett Micro Cap Growth F
Price$21.57
Change-$1.07 (-4.73%)
VolumeN/A
CapitalizationN/A
Vanguard Explorer Adm
Price$113.98
Change-$4.46 (-3.77%)
VolumeN/A
CapitalizationN/A
LFMGX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LFMGX vs. VEXRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFMGX is a StrongBuy and VEXRX is a Hold.

FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 23.9B vs. LFMGX (212M). VEXRX pays higher dividends than LFMGX: VEXRX (0.58) vs LFMGX (0.00). LFMGX was incepted earlier than VEXRX: LFMGX (4 years) vs VEXRX (23 years). LFMGX is a more actively managed with annual turnover of: 121.00 vs. VEXRX (40.00). LFMGX has a lower initial minimum investment than VEXRX: LFMGX (0) vs VEXRX (50000). LFMGX annual gain was more profitable for investors over the last year : 36.71 vs. VEXRX (17.14).
LFMGXVEXRXLFMGX / VEXRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence4 years23 years-
Gain YTD32.24314.734219%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets212M23.9B1%
Annual Yield % from dividends0.000.58-
Returns for 1 year36.7117.14214%
Returns for 3 years5.30-11.87-45%
Returns for 5 yearsN/A22.14-
Returns for 10 yearsN/A37.47-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOON0.600.03
+6.11%
Kartoon Studios
LILAK6.55-0.05
-0.76%
Liberty Latin America Ltd
CEG234.24-5.06
-2.11%
Constellation Energy Corp
ST29.48-0.77
-2.55%
Sensata Technologies Holding plc
VYGR6.25-0.23
-3.55%
Voyager Therapeutics